Home

Presidio Partners 2007, L.P.

CIK 1405712 · last filed 2015-12-17

Presidio Partners 2007, L.P. is a corporate insider who has filed 21 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for ARDX, was dated Dec 17, 2015. Across all open-market trades the lifetime net is −$50.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.6M across reported positions. The firm reports its address in San Francisco, CA. 48 SEC filings were submitted jointly with Presidio Partners 2007 (Parallel), L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.60M

Companies

2

Total Filings

21

Lifetime Open-Market Net

-$50.00M

Filer Profile

Reported Address
655 MONTGOMERY STREET, SUITE 6-161
San Francisco, CA 94111
Phone
(415) 613-8023
Formerly Known As
CMEA Ventures VII LP (2007–2015)
Related Filers
Presidio Partners 2007 (Parallel), L.P. — 48 joint filings, latest 2018-07-26
David J Collier — 8 joint filings, latest 2018-07-26
Presidio Partners 2007 GP, L.P. — 8 joint filings, latest 2018-07-26
James F Watson — 8 joint filings, latest 2018-07-26
Presidio Partners 2007 GP, LLC — 4 joint filings, latest 2016-04-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX 10%+ Owner 2,539,706 $3.78 $9.60M $0 2 2015-12-17
Auspex Pharmaceuticals, Inc. (ASPX) Delisted 10%+ Owner 3,041,610 — — -$50.00M 19 2015-02-17

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-12-17 ARDX Other (J) −600,000 $0 EDGAR
2015-02-17 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −245,334 -$15.48M EDGAR
2015-02-17 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −147,540 -$9.05M EDGAR
2015-01-02 ARDX Other (J) −800,000 $0 EDGAR
2014-12-22 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed −1,000,000 -$19.55M EDGAR
2014-11-12 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed — $0 EDGAR
2014-10-31 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −38,000 -$1.03M EDGAR
2014-10-29 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −29,000 -$783.6K EDGAR
2014-10-15 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed +71,714 -$11 EDGAR
2014-10-08 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed +71,714 -$11 EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.